WOCKHARDT
Back to Income Statement
|
WOCKHARDT Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹-463 Cr | ₹-559 Cr | ₹-244 Cr | ₹686 Cr | ₹-69 Cr |
What is the latest Consolidated Net Profit of WOCKHARDT ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹-463 Cr |
Mar2023 | ₹-559 Cr |
Mar2022 | ₹-244 Cr |
Mar2021 | ₹686 Cr |
Mar2020 | ₹-69 Cr |
How is Consolidated Net Profit of WOCKHARDT Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹-463 Cr | Negative | |
Mar2023 | ₹-559 Cr | Negative | |
Mar2022 | ₹-244 Cr | Negative | |
Mar2021 | ₹686 Cr | Positive | |
Mar2020 | ₹-69 Cr | - |
Compare Consolidated Net Profit of peers of WOCKHARDT
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WOCKHARDT | ₹21,424.0 Cr | -11.2% | -5.1% | 195.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,936.0 Cr | -5.8% | -3.2% | 35.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹152,157.0 Cr | -2.8% | -3.6% | 44.7% | Stock Analytics | |
CIPLA | ₹116,200.0 Cr | -3.9% | -0.5% | 13.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹111,325.0 Cr | -1.2% | 7.1% | 17.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,037.4 Cr | -2.7% | -0.1% | 40.9% | Stock Analytics |
WOCKHARDT Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WOCKHARDT | -11.2% |
-5.1% |
195.5% |
SENSEX | -2.1% |
-6.4% |
7% |
You may also like the below Video Courses